Introduction {#sec1-1}
============

Ayurvedic texts judge *Vata* as the most significant in the midst of the *tridoshas*, due to its six-fold distinguishing features like spreading, quick action, vigor, capability to vitiate other *doshas*, autonomy, and the power to create the maximum number of diseases.\[[@ref1]\] At the same time, it is also assumed that the life of living beings absolutely depends on *Rakta*.\[[@ref2]\] *Vatarakta* is an illness where both *vata* and *rakta* are afflicted by distinct etiological factors.\[[@ref3]\] The occurrence of *Vatarakta* is also possible when the customary *gati* of the *vata* is hindered by the morbid *kapha dosha* and *medas*.\[[@ref4]\]

The status of *Utthana vatarakta* is often compared with the atherosclerotic ischemic limb disease in the allied sciences due to the outstanding similarities. Atherosclerosis is a generalized phenomenon that can occur in any of the large- to medium-sized arteries. Atherosclerosis habitually does not present with any symptom until it brutally narrows an artery or blocks it completely. The type of artery and the location of the plaque vary from person to person. If either happens and blocks a blood vessel that feeds the heart, it can result in a heart attack. If it blocks the blood vessel that supplies blood to the brain, it results in a stroke. Furthermore, if the blood supply to the extremities is reduced, it can cause a complexity in walking and ultimately lead to gangrene. Peripheral arterial disease can impair physical health and diminish the ability to walk. If left untreated, it is the leading cause of foot or leg amputation. A person with peripheral arterial disease has six to seven times greater risk of death from coronary artery disease, heart attack, and stroke than the rest of the population.\[[@ref5]\]

The same thought has been highlighted in Ayurvedic literature under the designation of *Margavarana*. It is a widespread observable fact that ends up in a variety of disorders based on the site of the affliction. A reference of *Margavarana* involved in the pathogenesis is accessible in the contexts of *Hridroga, Gulma, Vatavyadhi, Vatarakta*, and so on. When the process of Margavarana takes place in the *rakta marga* due to the abnormal and excessive accumulation of morbid *kapha* and *medas* in the srotas, it ends up in the manifestation of *Vatarakta*.

Review of previous works done {#sec2-1}
-----------------------------

Close to 37 studies have been conducted all over India on *Vatarakta*.\[[@ref6]--[@ref9]\] An analysis reveals that most of the studies were carried out by considering *Vatarakta* as gouty arthritis or rheumatoid arthritis. Very few studies have been performed considering *Vatarakta* as an ischemic limb. Even after the towering prevalence of the disease in the present population, very few research studies have been conducted in this regard, which mainly deal with the outcome of the *Shodhana* therapies. However, the results of these small numbers of studies are extremely promising.

As it is an *Avaranajanya Vyadhi*, different preparations with drugs having *Srothosudhikaraka* and *Vyadhi Hara Rasayana*-properties like *Guggulu* are exclusively indicated in the management of *Vatarakta*. The herbal preparations like *Kaishora guggulu* and *Amrita guggulu*, consisting mainly of ingredients like *Guggulu (Commiphora mukul), Triphala (Terminalia chebula Retz, Terminalia bellerica, Emblica officinalis), Gudoochi (Tinospora cordifolia)*,\[[@ref10]\] and so on, are said to be useful in curing the illness.\[[@ref11]\]

Thus, getting immensely inspired by the above-mentioned data, the present study was carried out with a target to hit upon a better efficacious *Shamana Oushada* in stipulation of *Margavarana Janya Vatarakta*.

Aims and Objectives {#sec1-2}
===================

To evaluate and compare the efficacy of *Kaishora guggulu* and *Amrita guggulu* in patients suffering from *Utthana Vatarakta*.

Materials and Methods {#sec1-3}
=====================

Source of the data {#sec2-2}
------------------

The patients who attended the OPD and IPD of the S.D.M. Ayurveda Hospital, Kuthpady, Udupi, Karnataka, during the period of September 2006 to August 2007, with signs and symptoms of *Utthana Vatarakta*, were screened. Among these, 30 patients who fulfilled the criteria of inclusion, mentioned a little later in the text, were included in the study. The selected patients were randomly categorized into two groups, with each group consisting of 15 patients.

Inclusion criteria {#sec2-3}
------------------

Patients within the age group of 16 -- 70 years, presenting with *Pratyatmaka Lakshana* of *Utthana Vatarakta* and also with the symptoms of peripheral atherosclerotic disease were included in the study.

Exclusion criteria {#sec2-4}
------------------

Patients with severe toxicity, ulceration, progressive gangrenous changes, and suffering from diseases of immunological basis and syphilis were excluded from the study.

Investigations {#sec2-5}
--------------

Following are the investigations carried out on all 30 patients for the conduction of this study:

Hb%, ESR, RBS, lipid profile.Doppler ultrasound in selected patients.

Design {#sec2-6}
------

The study was a single-blind, comparative, clinical study with a pre-test and post-test design.

Intervention {#sec2-7}
------------

Group A: Fifteen patients with oral administration of Tab *Kaishora guggulu* in a dose of1 gthrice a day.

Group B: Fifteen patients with oral administration of Tab *Amrita guggulu* in a dose of 1 g thrice a day. Anupana-lukewarm water.

The study had received prior approval from the Institutional Ethical Committee.

Assessment criteria {#sec2-8}
-------------------

The assessment criteria is shown in [Table 1](#T1){ref-type="table"}.

###### 

Assessment criteria
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### Assessment of overall effect {#sec3-1}

Complete remission --- 100% relief.

Marked improvement --- reduction in the mean symptom score by 75 -- 99% of the initial score.

Moderate remission --- reduction in the mean symptom score by 50 -- 74%.

Average remission --- reduction in the mean symptom score by 25 -- 49%.

Unchanged --- reduction in the mean symptom score by \< 24% of the initial score.

Observations {#sec1-4}
============

Of the 30 patients of *Vatarakta* studied in this research, the maximum number of patients in both the groups (nearly 40%) belonged to the age group of 51 -- 60 years. Following this, the maximum number of patients was in the 61 -- 70 years age group. Sixty-six percent of the patients of group A and 73% of the patients of group B were male. The majority of patients in group A (73%) as well as group B (86%) were Hindus, in the present study. Eighty percent of the patients of group A and 93% of the patients of group B were married persons. It was observed that 26% of the females in group A and 20% from group B, in this study, were housewives. Also, it was found that the largest category of patients in both the groups was engaged in other occupations. The study revealed that most of the patients in both the groups belonged to the middle and the rich socioeconomic status (70%).

The present study revealed that 20% of the patients from both the groups had *Madhumeha* and 16.6% had *Shonita Mada* (hypertension). The maximum number of patients (73 and 66%) had the habit of taking a mixed diet. A dominance of *Madhura Rasa* in the diet was observed in most of the patients from both groups. Fifty percent of the patients of group A and nearly 60% of the patients in group B suffering from *Utthana Vatarakta* had the habit of smoking. In the present sample, all the patients in both the groups had *Dvandvaja Praktiti*. Also, in the present study, all the patients had *Madhyama Samhanana*. Similarly, in the present sample of patients suffering from *Santarpanajanya Vatarakta*, more than 80% of the patients in both the groups had either *Pravara* or *Madhyama, Abhyavaharana*, and Jarana Shakti. Of the 30 patients suffering from *Vatarakta* taken for the study, 70% of the patients had gradual onset of the disease, and in 30%, the onset was insidious. None of the patients had a sudden onset of illness.

Results and Discussion {#sec1-5}
======================

*Vatarakta* is a *Vatavyadhi Prabheda*. The illness is considered to be the finest illustration of an *Avarana Vyadhi*, as an opening from the etiopathogenesis to the complications, the illness follows the characteristic presentation of *Avarana*. Compared with the other *Vatavyadhi, Vatarakta* possesses a special place in the literature, due to its high prevalence in the society, increased incidence as age advances, step-wise succession, and so on.

From the overall view of the etiology, it is obvious and unambiguous that the precise etiological factors of *Vata Dosha* as well as *Rakta Dhatu* are accountable for the causation of illness. At the same time, an alternate form of *Vatarakta* also exists, which is the result of *Kapha-medo Avarana* in *Rakta Marga*. Whatever be the grounds, an obstruction in the path of *Rakta Dhatu* is the core pathology of the disease.

Of the 30 patients of *Vatarakta* studied in this research, the maximum number of patients in both the groups belonged to the age group of 51 -- 60 years and 61 -- 70 years, respectively. It is an established fact that atherosclerosis usually becomes symptomatic during the fifth or sixth decade of life. The present observation of 70% of the patients between these two age groups corroborates the same. The illness definitely has a predilection for the male sex compared to the female sex, till the menopausal age. Sixty-six percent of the patients of group A and 73% of the patients of group B were males. This shows the increased incidence of the disease in males. The study revealed that most of the patients in both the groups belonged to the middle and rich socioeconomic status. Inactive life fashion is ordinary among this category of people. Sedentary lifestyle has a clear-cut role in the causation of the illness. Similarly, the sample indicates the prevalence of the illness in middle and higher class people. Apart from *Vatarakta*, the common disorders were aberration of *medas*, seen as *Madhumeha, Shoniata Mada* (hypertension), and *Hridroga*. In agreement with the etiology and basic pathology that is common in these diseases, they tend to coexist in patients, as in the present study, revealing the same tendency, wherein 80% of the patients from both the groups had *Madhumeha, Shonita Mada* or both.

The dominance of the *Madhura Rasa* in the diet of most of the patients from both groups once again confirms the role of the *Kapha*- and *Meda*-vitiating factors in the production of the illness. The *Abhyavaharana* or *Jarana Shakti* of the persons indicates the possibility of *Santarpana* or otherwise. moderate or good *Abhyavaharana Shakti*, and *Jarana Shakti* indicates the high probability of indulgence in *Santarpana*, leading to disease manifestation. Similarly, in the present sample of patients suffering from *Santarpanajanya Vatarakta*, more than 80% of the patients in both groups had either Pravara or *Madhyama Abhyavaharana* and *Jarana Shakti*. Smoking is one among the most established risk factors of atherosclerosis. Fifty percent of the patients of group A and nearly 60% of the patients in group B suffering from *Utthana Vatarakta* had the habit of smoking.

Patients of both groups, A and B, showed marked remission of the symptom of pain after intervention. The results are shown in Tables [2](#T2){ref-type="table"}--[4](#T4){ref-type="table"}. The comparison of effect of therapy is shown in Figures [1](#F1){ref-type="fig"}--[4](#F4){ref-type="fig"}. In group A, the initial mean score was 1.40, which came down to 0.933 after treatment, exhibiting a statistically, highly significant improvement, with *P* \< 0.001 and about 66.6% relief. At the same time, group B patients also showed marked improvement, with reduction in the initial mean score of 1.26 to 0.46 after intervention. This was statistically, highly significant, with *P* \< 0.001 and about 63.14% relief. When compared, through the unpaired "*t*" -test, the difference between the two groups was not significant statistically. Burning sensation was one of the cardinal symptoms of *Vatarakta*, which was relieved by 66% in group A patients and by 55% in group B patients. This improvement, when compared using the unpaired "*t*" -test, did not show any difference between the two groups. Seventy-six percent improvement was observed in the symptom of 'malaise' in group A patients, while Group B patients showed 73% relief. This improvement after the treatment was found to be highly significant (*P* \< 0.001) in both the groups as per the paired "*t*" -test. When given for the unpaired "*t*" -test, this difference was not statistically significant. It showed that *Kaishora guggulu* and *Amrita guggulu* were equally helpful in managing the symptom of malaise.

###### 

Effect of therapy on the subjective and objective parameters in patients of group A
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###### 

Effect of therapy on subjective and o bjective parameters in patients of group B
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###### 

Comparison of the effect of treatment in both groups using the unpaired t-test
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![Comparison of the effect of treatment on pain](Ayu-31-410-g005){#F1}

![Comparison of the effect of treatment on local color change](Ayu-31-410-g006){#F2}

![Comparison of the effect of treatment on peripheral pulses](Ayu-31-410-g007){#F3}

![Overall effect of treatment](Ayu-31-410-g008){#F4}

Tenderness is another symptom of *Vatarakta*. In group A, the initial mean score of the patients for tenderness was 1.00, which was reduced to 0.20 after the treatment. In group B, the initial mean score of the patients for tenderness was 1.00, which was reduced to 0.26. The improvement was 80% and 73%, respectively. This improvement was statistically significant in both groups. The unpaired "*t*" -test showed equal efficacy of *Kaishora guggulu* and *Amrita guggulu* in this regard as the difference was not statistically significant. In case of the symptom of edema, the change that occurred with the treatment in both groups was greater than what could be expected by chance; there was a statistically significant change (*P* \< 0.010), as assessed by the paired "*t*" -test. As per the unpaired "*t*" -test, this difference was not a statistically significant one. Thus, *Kaishora guggulu* and *Amrita guggulu* were equally effective in managing the symptom of edema. Patients treated with Kaishora guggulu in group A and with *Amrita guggulu* in group B had no significant difference in local color changes. The difference obtained in group A was not statistically significant (*P* = 0.164). In group B patients, the initial score of 1.00 remained the same even after treatment. In unpaired "*t*" -test, the difference mean showed by group A was 0.133 against the 0.000 difference in the mean of group A. However, this change could not be concluded because of the higher efficacy of *Kaishora guggulu* on local color change. Forty-five percent improvement was observed in the score of walking ability in group A; 1.467 was the initial mean score recorded in the 15 patients of *Utthana Vatarakta* This was brought down to 0.800 after the administration of *Kaishora guggulu*. In the second group, the initial mean score was 1.33, which was reduced to 0.733, showing 45% improvement. This improvement after the treatment was found to be highly significant (*P* \< 0.001) as per the paired "*t*" -test. The unpaired "*t*" -test showed equal efficacy of both the yogas in dealing with the same. The mean initial score of peripheral pulses was 1.400 before the treatment, in patients of *Utthana Vatarakta* of group A. This initial mean score came down to 1.00 after the treatment. The improvement to the tune of 28% was significant (*P* = 0.009), as revealed by the paired "*t*" -test. In group B, the initial mean score was 1.200, which reduced to 0.200 after the intervention. This change in group B was not statistically significant as the *P*-value suggested *P* = 0.082. However, this higher response was not statistically significant according to the unpaired "*t*" -test.

The overall assessment in both the groups revealed equal efficacy of both the *yogas* in managing the illness. Sixty-six percent of the patients from both the groups showed an average remission of symptoms and signs. Moderate remission was observed in nearly 13% of the patients. None of the patients from both the groups showed complete remission or marked improvement. In the remaining 20% of the patients in each group, the tune of improvement was \> 24%, which came under the unchanged category.

All the 30 patients taken for the study had some or the other form of improvement in the symptoms of *Vatarakta*.

In short, when the overall assessment was performed, both the groups did not show any remarkable difference in the final results. Both *Kaishora guggulu* and *Amrita guggulu* were equally effective in the management of *Margavaranajanya Vatarakta*. However, an individual analysis of the symptoms assessed in both groups by the paired "*t*" -test showed minor differences. Fifteen patients of group A treated with *Kaishora guggulu* showed relatively marginal improvement in almost all the symptoms and signs of *Utthana Vatarakta*. Even then, these differences were not significant from the statistical view point. Thus, these insignificant improvements observed in group A could not be concluded as the better efficacy of *Kaishora guggulu* in treating the illness of *Santarpana Nidanajanya Margavaranaja Utthana Vatarakta*. Here, the marginal difference observed could be due to the random sampling variability.

Probable mode of action {#sec2-9}
-----------------------

Obstruction in the *Rakta Vaha Srotas* causing hindrance to the normal movement of the *Vata Dosha*, is the root pathology behind the manifestation of the illness *Vatarakta*. This obstruction is established by the arterial color Doppler study.

In case of *Santarpana Nidana Janya Vatarakta*, the approach toward the management varies. Here, the objective of the entire treatment is to eliminate the *Margavarana* that has already occurred and is progressing in the *Rakta Vaha Srotas*. Therefore, in the initial stage of handling, the administration of *Snehana* and *Bhruhmana* are contraindicated.

In this situation, one has to go for *Kapha-Medo Kshapana Chikitsa*. Practically, this is implemented by methods of physical exercises, *Virechana, gomutra-shilajatu-guggulu prayoga*, and so on. After clearing the root of *Rakta* and *Vata*, the general line of management of *Vatarakta* is useful. *Kaishora guggulu* and *Amrita guggulu* are the two significant *yogas* taken from *Bhaishajya Ratnavali* and are indicated in *Vatarakta Chikitsa*. The combination and properties of the drugs in both the preparations shows the efficiency of the *yogas* in clearing the *Margavarana*. In both the preparations, *Guggulu, Gudoochi*, and *Triphala* are the chief ingredients.

*Guggulu* is one extraordinary drug that possesses *Anabhishyandhi, Snigdha*, and *Sroto Shuhdhikaraka* actions. It is considered as the best drug for the management of *Meda Avruta Anila*. It is the best drug that can be administered in this condition, as it is proved that it has an optimistic outcome in negating the incriminatory action of the morbid *Kapha Dosha* as well as the *Medo Dhatu*.

*Guduchi* is the drug of choice in *Vatarakta*. It acts as *Vyadhipratyneeka* and is a magnificent *Rasayana. Triphala* is well known for its *Rookshana* and *Kapha Medo Hara* effects. All the other ingredients of the *yogas* also work in the same pattern.

Apart from these, the recent experimental studies performed on these drugs also reveal the same; that the ingredients in both the *yogas* are highly efficacious in treating the state of hyperlipidemia. These points are good enough to support the selection of these two *yogas* for the present comparative study in the management of *Vatarakta*.

The *Rookshana* property of drugs like *Danti (Baliospermum montanum), Triphala (Terminalia chebula Retz., Terminalia bellerica, Emblica officinalis), Vidanga (Embelia ribes)*, and *Guggulu (Commiphora mukul)* are believed to act on abnormally accumulated *Kapha Dosha* and *Medas. Tikshna* and *ushna* drugs like *Pippali, Shunthi, Maricha, Vidanga, Danti*, and so on, are present in *Kaishora guggulu* as well as *Amrita guggulu*, and *Guggulu* is stated to have a positive action on *Srotovishodhana*. The same is reflected in the results, as there is a definite improvement in the walking ability and marginal improvement in peripheral pulses.There is clear - cut evidence for improvement in circulation.Improvement in circulation means reduction in *Margavarana*, which in turn leads to reduced morbidity of *Vata Dosha*.

Apart from this, ingredients like *Guggulu* definitely have an action on the pacification of *Vata Dosha* too. Therefore, the average positive response obtained in a major percentage of patients taken for the study can be well understood as remission of *Margavarana* to a certain level and also due to release in the obstruction of *Vata Dosha*.

The average remission of symptoms observed in the results of both the groups definitely shows a marginal improvement in the circulation and a resultant pacification of the morbid *Vata Dosha* to a certain extent following the medication. Reduction in the chief presenting symptoms like pain, burning sensation, and malaise also indicates reduction in the morbidity of *Vata Dosha*.

Marginal improvement in the symptom of the local color change is suggestive of reduction in the severity of the morbidity of *Rakta Dhatu*. The changes seen after the intervention in both the groups are definitely satisfactory. The therapeutic efficacy of *Kaishora guggulu* and *Amrita guggulu* in *Utthana Vatarakta* has proved to be similar. However, the ultimate aim of complete remission of *Margavarana* and total relief from the symptoms has not yet been achieved. In short, of course, the results are constructive, but not complete.

Conclusion {#sec1-6}
==========

The entire notion of *Margavarana* can be well correlated to the pathology of atherosclerosis, and the state of *Utthana Vatarakta* to that of Peripheral arterial disease in the modern dialect. Results show noticeable improvement in the symptoms and signs of *Utthana Vatarakta* after the intervention in both the groups. The outcome of the study reveals the identical therapeutic efficacy of *Kaishora guggulu* and *Amrita guggulu* in *Utthana Vatarakta*. The use of *Kaishora guggulu* or *Amrita guggulu* as Shamana Oushadhas is a perfect selection for the management of *Rakta Margavaranajanya Utthana Vatarakta*.
